198 related articles for article (PubMed ID: 7036330)
1. Papillary necrosis in vitro: a scanning electron microscopic comparison of escherichia coli and Proteus mirabilis infection.
Cohen MS; Davis CP; Baur PS; Warren MM
Scan Electron Microsc; 1981; (Pt 3):65-72. PubMed ID: 7036330
[TBL] [Abstract][Full Text] [Related]
2. Scanning electron microscopic examinations of renal stones associated with urinary infections.
Hirano S; Ohkawa M; Hisazumi H
Nihon Jinzo Gakkai Shi; 1987 Mar; 29(3):293-300. PubMed ID: 3302428
[No Abstract] [Full Text] [Related]
3. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
Mobley HL; Island MD; Massad G
Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
[TBL] [Abstract][Full Text] [Related]
4. [Experimental bladder stone production by human uropathogenic bacteria].
Arai Y; Takeuchi H; Tomoyoshi T
Hinyokika Kiyo; 1997 Mar; 43(3):207-11. PubMed ID: 9127756
[TBL] [Abstract][Full Text] [Related]
5. Mortality in murine peritonitis correlates with increased Escherichia coli adherence to the intestinal mucosa.
Burch PT; Scott MJ; Wortz GN; Peyton JC; Cheadle WG
Am Surg; 2004 Apr; 70(4):333-41. PubMed ID: 15098788
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on the role of bacteria from urinary tract infections on the bladder carcinogenesis].
Kaji S
Fukuoka Igaku Zasshi; 1994 Oct; 85(10):294-308. PubMed ID: 7995611
[TBL] [Abstract][Full Text] [Related]
7. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.
Fraga M; Scavone P; Zunino P
Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974
[TBL] [Abstract][Full Text] [Related]
8. Different binding specificities of P. mirabilis compared to E. coli.
Lomberg H; Larsson P; Leffler H; Svanborg-Edén C
Scand J Infect Dis Suppl; 1982; 33():37-42. PubMed ID: 6753134
[TBL] [Abstract][Full Text] [Related]
9. Effect of LPS on epithelial integrity and bacterial uptake in the polarized human enterocyte-like cell line Caco-2.
Wells CL; Jechorek RP; Olmsted SB; Erlandsen SL
Circ Shock; 1993 Aug; 40(4):276-88. PubMed ID: 8375030
[TBL] [Abstract][Full Text] [Related]
10. Effects of the pH and the urine infected by Escherichia coli and Proteus mirabilis on chromic catgut, polyglycolic acid and polyglactin 910: study in vitro.
Hering FL; Rosenberg D; Chade J
Urol Int; 1989; 44(4):231-4. PubMed ID: 2552634
[TBL] [Abstract][Full Text] [Related]
11. Analysis of inflammatory cytokine expression in the urinary tract of BALB/c mice infected with Proteus (P.) mirabilis and enteroaggregative Escherichia (E.) coli (EAEC) strains.
Melendez-Avalos A; Sainz-Espuñes T; Castrillón-Rivera LE; Mendoza-Pérez F; Palma-Ramos A; Castañeda-Sánchez JI; Drago-Serrano EM
Folia Microbiol (Praha); 2020 Feb; 65(1):133-142. PubMed ID: 31104302
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
[TBL] [Abstract][Full Text] [Related]
13. Integrin expression, enterocyte maturation, and bacterial internalization.
Hess DJ; Henry-Stanley MJ; Moore EA; Wells CL
J Surg Res; 2001 Jun; 98(2):116-22. PubMed ID: 11397127
[TBL] [Abstract][Full Text] [Related]
14. Observations on the adherence of Proteus mirabilis onto polymer surfaces.
Stickler DJ; Lear JC; Morris NS; Macleod SM; Downer A; Cadd DH; Feast WJ
J Appl Microbiol; 2006 May; 100(5):1028-33. PubMed ID: 16630003
[TBL] [Abstract][Full Text] [Related]
15. Chronic urinary tract infection in dogs: induction by inoculation with bacteria via percutaneous nephropyelostomy.
Ling GV; Lowenstine LJ; Cullen JM; Ackerman N; Ruby AL
Am J Vet Res; 1987 May; 48(5):794-8. PubMed ID: 3296890
[TBL] [Abstract][Full Text] [Related]
16. Benurestat, a urease inhibitor for the therapy of infected ureolysis.
Andersen JA
Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613
[TBL] [Abstract][Full Text] [Related]
17. Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model.
Cadieux PA; Chew BH; Knudsen BE; Dejong K; Rowe E; Reid G; Denstedt JD
J Urol; 2006 Jun; 175(6):2331-5. PubMed ID: 16697868
[TBL] [Abstract][Full Text] [Related]
18. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin.
Alamuri P; Mobley HL
Mol Microbiol; 2008 May; 68(4):997-1017. PubMed ID: 18430084
[TBL] [Abstract][Full Text] [Related]
19. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus.
Perrone G; Ferrari C; Arghittu M
Boll Ist Sieroter Milan; 1982; 61(6):513-5. PubMed ID: 6765400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
